SLC16A3 and cancer: In this study, we attempt to elucidate the structural features of MCT4, for specified substrate recognition, through an in silico molecular modelling pipeline as a therapeutic approach towards the identification of potent inhibitors of MCT4 as a significant protein in cancer recognition and metabolic pathways.